Doseology Sciences Inc. Stock OTC Markets
Stocks
DOSEF
CA2584842033
Pharmaceuticals
OTC Markets Traded|
Real-time
OTC Markets
10:45:11 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.2500 USD | -.--% |
|
+124.42% | -28.57% |
| 1 week | +124.42% | ||
| Current month | +124.42% | ||
| 1 month | +124.42% | ||
| 3 months | -19.17% | ||
| 6 months | -52.83% | ||
| Current year | -28.57% |
| Current year | 0.01 |  | 0.68 |
| 1 year | 0.01 | | 0.68 |
| 3 years | 0.01 | | 1.83 |
| 5 years | 0.01 | | 1.83 |
| 10 years | 0.01 | | 1.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chris Jackson
CEO | Chief Executive Officer | 56 | 2025-04-30 |
| Chief Executive Officer | 47 | 2024-05-12 | |
Basin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Vice
BRD | Director/Board Member | 37 | 2021-04-01 |
Scott Reeves
BRD | Director/Board Member | 57 | 2020-05-26 |
| Director/Board Member | 55 | 2024-01-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +124.42% | - | - | 844K | |
| -0.68% | +5.27% | +79.13% | +127.29% | 1,119B | |
| +0.89% | +3.94% | +52.86% | +65.19% | 651B | |
| -0.15% | +5.74% | +27.53% | +80.52% | 468B | |
| -1.38% | +4.02% | +42.52% | +42.38% | 374B | |
| -0.52% | +2.72% | +25.21% | +41.06% | 302B | |
| -1.06% | +4.76% | +2.00% | +12.65% | 259B | |
| +0.90% | +5.71% | +53.68% | +72.75% | 238B | |
| -0.53% | +2.34% | -18.53% | -53.66% | 208B | |
| +0.16% | +5.48% | +28.36% | +91.96% | 181B | |
| Average | -0.26% | +5.17% | +32.53% | +53.35% | 422.21B | |
| Weighted average by Cap. | -0.30% | +5.40% | +45.77% | +72.87% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- MOOD Stock
- DOSEF Stock
Select your edition
All financial news and data tailored to specific country editions
